Integer (ITGR) Issues FY18 Earnings Guidance

Integer (NYSE:ITGR) issued an update on its FY18 earnings guidance on Thursday morning. The company provided EPS guidance of $3.15-3.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.23. The company issued revenue guidance of $1.49-1.53 billion, compared to the consensus revenue estimate of $1.47 billion.

Shares of Integer (NYSE ITGR) traded up $7.10 during midday trading on Friday, reaching $52.45. 292,988 shares of the company were exchanged, compared to its average volume of 148,768. The firm has a market cap of $1,434.64, a price-to-earnings ratio of 83.10, a PEG ratio of 0.99 and a beta of 1.05. The company has a debt-to-equity ratio of 1.95, a quick ratio of 1.37 and a current ratio of 2.58. Integer has a 12-month low of $33.90 and a 12-month high of $55.20.

Integer (NYSE:ITGR) last announced its earnings results on Thursday, February 22nd. The medical equipment provider reported $0.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.79 by $0.17. The firm had revenue of $390.50 million during the quarter, compared to analyst estimates of $358.42 million. Integer had a net margin of 1.42% and a return on equity of 11.22%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.87 EPS. analysts expect that Integer will post 2.64 earnings per share for the current fiscal year.

ITGR has been the subject of a number of research analyst reports. BidaskClub lowered shares of Integer from a buy rating to a hold rating in a research note on Saturday, November 4th. TheStreet lowered shares of Integer from a b- rating to a c+ rating in a research note on Thursday, November 9th. ValuEngine raised shares of Integer from a hold rating to a buy rating in a research note on Sunday, December 31st. Zacks Investment Research upgraded shares of Integer from a sell rating to a buy rating and set a $51.00 price objective for the company in a research note on Wednesday, December 27th. Finally, Royal Bank of Canada restated a neutral rating on shares of Integer in a research note on Friday, October 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of Hold and an average price target of $51.00.

In other news, COO Jeremy Friedman sold 8,163 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $44.89, for a total transaction of $366,437.07. Following the completion of the transaction, the chief operating officer now directly owns 17,673 shares in the company, valued at approximately $793,340.97. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, VP Timothy G. Mcevoy sold 3,500 shares of the stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $49.35, for a total transaction of $172,725.00. Following the transaction, the vice president now owns 32,401 shares of the company’s stock, valued at $1,598,989.35. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 64,286 shares of company stock valued at $2,996,350. Company insiders own 4.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Integer (ITGR) Issues FY18 Earnings Guidance” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/23/integer-itgr-issues-fy18-earnings-guidance.html.

Integer Company Profile

Greatbatch, Inc is a developer and manufacturer of medical devices and components. The Company operates through two segments: Greatbatch Medical and QiG Group (QiG). Greatbatch Medical designs and manufactures products where the Company either owns the intellectual property or has unique manufacturing and assembly expertise.

Earnings History and Estimates for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply